Porta-Pardo Eduard, Kamburov Atanas, Tamborero David, Pons Tirso, Grases Daniela, Valencia Alfonso, Lopez-Bigas Nuria, Getz Gad, Godzik Adam
Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
Department of Pathology and Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Nat Methods. 2017 Aug;14(8):782-788. doi: 10.1038/nmeth.4364. Epub 2017 Jul 17.
Understanding genetic events that lead to cancer initiation and progression remains one of the biggest challenges in cancer biology. Traditionally, most algorithms for cancer-driver identification look for genes that have more mutations than expected from the average background mutation rate. However, there is now a wide variety of methods that look for nonrandom distribution of mutations within proteins as a signal for the driving role of mutations in cancer. Here we classify and review such subgene-resolution algorithms, compare their findings on four distinct cancer data sets from The Cancer Genome Atlas and discuss how predictions from these algorithms can be interpreted in the emerging paradigms that challenge the simple dichotomy between driver and passenger genes.
了解导致癌症起始和进展的遗传事件仍然是癌症生物学面临的最大挑战之一。传统上,大多数用于识别癌症驱动基因的算法都在寻找那些突变数量超过平均背景突变率预期的基因。然而,现在有各种各样的方法,它们将蛋白质内突变的非随机分布视为癌症中突变起驱动作用的信号。在这里,我们对这类亚基因分辨率算法进行分类和综述,比较它们在来自癌症基因组图谱的四个不同癌症数据集上的发现,并讨论如何在挑战驱动基因和乘客基因简单二分法的新兴范式中解释这些算法的预测结果。